Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Apr 25, 2017
Scale-up of a DPI carrier-based formulation and blending process optimization
Read more
Scientific Article
/ Apr 25, 2017
Paddle Over Disk as a Dissolution Test for Orally Inhaled Fluticasone Propionate
Read more
Scientific Article
/ Apr 25, 2017
Optimization of Formulation and Process Parameters for the Manufacture of Inhalable Composite Particles by Spray-Drying
Read more
Scientific Article